Synthesis and evaluation of antimicrobial and anticonvulsant activities of some new 3-[2-(5-aryl-1,3,4-oxadiazol-2-yl/4-carbethoxymethylthiazol-2-yl)imino- 4-thiazolidinon-5-ylidene]-5-substituted/nonsubstituted 1H-indole-2-ones and investigation of their structure-activity relationships

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 3, 2006, Pages 239-248

  Altintaş, Handan ^a   Ateş, Öznur ^a   Uydeş Doǧan, B Sönmez ^a   Alp, F Ilkay ^a   Kaleli, Deniz ^a   Özdemir, Osman ^a   Birteksöz, Seher ^a   Ötük, Gülten ^a   Şatana, Dilek ^b   Uzun, Meltem ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

1H Indole 2 one 3 ylidene derivatives, antimicrobial and anticonvulsant activities, 5 substituted nonsubstituted, synthesis; Anticonvulsants; Antimicrobials

Indexed keywords

1H INDOLE 2 ONE DERIVATIVE; 2 [(1,3,4 OXADIAZOL 2 YL)IMINO] 4 THIAZOLIDINONE (DI,II) DERIVATIVE; 2 [(4 CARBETHOXYMETHYL THIAZOL YLIMINO] 4 THIAZOLIDINONE DERIVATIVE; 2 [(CHLOROACETYL)AMINO] 1,3,4 OXADIAZOLE (CI,II) DERIVATIVE; 4 CARBETHOXYMETHYL 2 [(CHLOROACETYL)AMINO]THIAZOLE DERIVATIVE; CEFUROXIME; INDOLE DERIVATIVE; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANTICONVULSANT ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED RADIATION; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RADIOMETRY; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET RADIATION;

EID: 33645470717     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296716     Document Type: Article

References (33)

1. Ates, Ö., Kocabalkanli, A., Ötük, G. et al., Synthesis and antibacterial activity of 5-aryl-2-[(α-chloro-α-phenylacetyl/ α-bromopropionyl)amino]-1,3,4-oxadiazoles and 2-[(5-aryl-1,3,4-oxadiazol- 2-yl)imino]-5-phenyl/methyl-4-thiazolidinones. Arzneim.-Forsch./Drug Res. 47, 1134 (1997)
2. Ulusoy, N., Çapan, G., Ergenç, N. et al., Synthesis and antimicrobial activity of novel imidazo[2,1-b]thiazolyl acetylamino]hydrazono 4-thiazolidinones. Acta Pharm.Sci. XXXIX, 181 (1997)
3. Gahane, D. R., Khapekar, K. D., Sharma, V. C. et al., Mannich reaction products of 5-arylidene-2-phenylimino-4-thiazolidinones as anticonvulsants. Indian J. Pharm. Sci. 60, 275 (1998)
4. Ateş, Ö., Altintaş, H., Ötük, G., Synthesis and antimicrobial activity of 4-carbethoxymethyl-2-[(α-haloacyl)amino] thiazoles and 5-nonsubstituted/substituted 2-[(4-carbethoxymethylthiazol-2-yl) imino]-4-thiazolidinones. Arzneim.-Forsch./Drug Res. 50, 569 (2000)
5. Heymes, R., 7-Aminothiazolylacetamidocephalosporanic acid derivatives. Ger. Offen. 2,700,552 (1977); Ref. C.A. 87, 152245t (1977)
6. Korea, S., Preparation of antibacterial ammonia cephalosporins. Jpn. Kokai Tokkyo Koho JP 08,283,274 (1995); Ref. C.A. 126, 74673p (1997)
7. Dong, H. S., Zhang, Z. Y., Hui, X. P. et al., Synthesis of 2-arylimino-5-[5′-amino-1′-(4″-chlorophenyl)-1′, 2′,3′-triazol-4′-yl]-1,3,4-oxadiazoles. Youji Huaxue 18, 253 (1998); Ref. C.A. 129, 67738 (1998)
8. Kachroo, P. L., Gupta, R., Gupta, S. C. et al., Synthesis of some substituted 1,3,4-oxadiazoles, their antibacterial and antiamebic activity. Natl. Acad. Sci. Lett. (India) 13, 125 (1991); Ref. C.A. 115, 49539g (1991)
9. Amir, M., Oberoi, A., Alam, S., Synthesis and antiinflammatory activity of some new 6-methoxy-α-methyl-2-naphthaleneacetic acid derivatives. Indian J. Chem. Sect. B: Org. Chem. Incl. Med. Chem. 38, 237 (1999); Ref. C.A. 131, 5225 (1999)
10. Akerblom, E. B., Synthesis and structure-activity relationships of a series of antibacterially active 5-(5-nitro-2-furfurylidene) thiazolones, 5-(5-nitro-2-furylpropenylidene)thiazolones and 6-(5-nitro-2-furyl)-4H-1,3- thiazinones. J. Med. Chem. 17, 609 (1974)
11. Kirichenko, B. M., Steblyuk, P. M., Vladzimirskaya, E. V. et al., Synthesis and properties of 3-(2′-carbomethoxyfuryl-5′-yl)methyl-2, 4-dioxothiazolidine and their derivatives. Farm.Zh. (Kiev) 5, 39 (1979); Ref. C.A. 92, 146660m (1980)
12. Rida, S. M., Salama, H. M., Labouta, I. M. et al., Synthesis of some 3-(benzimidazol-2-ylmethyl)thiazolidinone derivatives as potential antimicrobial agents. Pharmazie 40, 727 (1985)
13. Tkachuk, B. V., Some transformations of the antimicrobial drug ciminal. Farm. Zh. (Kiev) 5, 46 (1979); Ref. C.A. 92, 128788 (1980)
14. Popp, F. D., Donigan, B. E., Synthesis of 3-hydroxy-3-phenacyloxindole analogs. J. Pharm. Sci. 68, 519 (1979)
15. Popp, F. D., Parson, R., Donigan, B. E., Potential anticonvulsants. III. The condensation of isatin with cyclic ketones. J. Heterocycl. Chem. 17, 1329 (1980)
16. Karali, N., Terzioglu, N., Gürsoy, A., Synthesis and structure-activity relationships of 3-hydrazono-1H-2-indolinones with antituberculosis activity. Arzneim.-Forsch./Drug Res. 48, 758 (1998)
17. Performance Standards for Antimicrobial Disk Susceptibility Tests; 7th ed. Approved Standard M2-A7 NCCLS. National Committee for Clinical Laboratory Standards, Wayne, PA (2000)
18. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; 5.ed. Approved Standard M7-A5 NCCLS. National Committee for Clinical Laboratory Standards, Wayne, PA (2000)
19. Inderleid, C. B., In: Antibiotics in Laboratory Medicine, 3rd ed., V. Lorian (ed.), pp. 134, William and Wilkins, Baltimore (1991)
20. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard M 27-A. National Commitee for Clinical Laboratory Standards, Wayne, PA (1997)
21. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; Proposed standard M 38-P. National Commitee for Clinical Laboratory Standards, Wayne, PA (1998)
22. Fernandez, T. B., Cabanes, F. J., Carillo-Munoz A. et al., Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J. Clin. Microbiol. 40, 3999 (2002)
23. Fernandez, T. B., Carillo A. J., Martin, E. et al., In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob. Agents Chemother. 45, 2524 (2001)
24. Gupta, A. K., Kohli, Y., Clinical and laboratory investigations in vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes and in vitro evaluation of combination antifungal activity. Br. J. Dermatol. 149, 296 (2003)
25. Espinel-Ingroff, A., Kigh, C. W., Kerkering, T. M. et al., Collaborative comparision of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol., 30, 3138 (1992)
26. Rodriguez-Tudela, J. L., Berenguer, J., Martinez-Suare J. V. et al., Comparision of a spectrophotometric microdilution method with RPMI-2% glucose with the national commitee for clinical laboratory standard reference macrodilution method M 27-P for in vitro susceptibility testing of amphotreicin B, Flucytosine and fluconazole against Candida albicans. Antimicrob. Agents Chemother. 40, 1998 (1996)
27. Osonoe, K., Mori, N., Suzuki, K. et al., Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res. 663, 338 (1994)
28. Dogan, H. N., Duran, A., Rollas, S. et al., Sythesis of new 2,5-Disubstituted-1,3,4-thiadiazoles and preliminary evalulation of anticonvulsant and antimicrobial activities. Bioorg. Med. Chem. 10, 2893 (2002)
29. Scott, F. L., Lambe, T. M., Butler, R. N., Ambident oxidative ring closure of semicarbazones. J. Chem. Soc. Perkin Trans 1, 1918 (1972)
30. Ateş, Ö., Kocabalkanli, A., Saniş, G. Ö. et al., Synthesis and antibacterial activity of 5-aryl-2-[(α-chloro-(- phenylacetyl/α-bromopropionyl)amino]-1,3,4-oxadiazoles and 2-[(5-aryl-1,3,4-oxadiazol-2-yl)imino]-5-phenyl/methyl-4-thiazolidinones. Arzneim.-Forsch./Drug Res. 47, 1134 (1997)
31. Rao, R. P., Preparation of some 3-(2-arylimino-4-oxo-5- thiazolidinylidene)oxindoles. J. Sci. Ind. Res. 19B, 29 (1960); Ref. C.A. 54, 17376d (1960)
32. Büyüktimkin, S., Chinazolinone. 4. Mitteilung: Synthese von Derivaten des 2-Methyl-3-(4-oxothiazolidin-2-ylidenamino)-4(3H)-chinazolinons. Pharmazie 40, 393 (1985)
33. Karali, N., Synthesis and primary cytotoxicity evaluation of new 5-nitroindole-2,3-dione derivatives. Eur. J. Med. Chem. 37, 909 (2002)